Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0
AP Chen, A Setser, MJ Anadkat, J Cotliar… - Journal of the American …, 2012 - Elsevier
Dermatologic adverse events to cancer therapies have become more prevalent and may to
lead to dose modifications or discontinuation of life-saving or prolonging treatments. This
has resulted in a new collaboration between oncologists and dermatologists, which requires
accurate cataloging and grading of side effects. The Common Terminology Criteria for
Adverse Events Version 4.0 is a descriptive terminology and grading system that can be
used for uniform reporting of adverse events. A proper understanding of this standardized …
lead to dose modifications or discontinuation of life-saving or prolonging treatments. This
has resulted in a new collaboration between oncologists and dermatologists, which requires
accurate cataloging and grading of side effects. The Common Terminology Criteria for
Adverse Events Version 4.0 is a descriptive terminology and grading system that can be
used for uniform reporting of adverse events. A proper understanding of this standardized …